健康研究
健康研究
건강연구
HEALTH RESEARCH
2015年
4期
361-366
,共6页
慢性乙型肝炎%抗病毒治疗%乙肝病毒共价闭合环状DNA%乙肝表面抗原
慢性乙型肝炎%抗病毒治療%乙肝病毒共價閉閤環狀DNA%乙肝錶麵抗原
만성을형간염%항병독치료%을간병독공개폐합배상DNA%을간표면항원
CHB%antiviral therapy%ccc DNA%HBsAg
国际学术界主流观点和WHO推荐意见:即使在欠发达国家,仍然要创造条件优先选用高效低耐药的药物治疗,以避免因高耐药性所导致的一系列医学和卫生经济问题。本文复习慢性乙型肝炎抗病毒治疗新进展,包括:抗病毒治疗后清除HBsAg和降低肝内cccDNA、单药治疗、联合治疗、NA对肾功能影响、研究和治疗应答的预测等。
國際學術界主流觀點和WHO推薦意見:即使在欠髮達國傢,仍然要創造條件優先選用高效低耐藥的藥物治療,以避免因高耐藥性所導緻的一繫列醫學和衛生經濟問題。本文複習慢性乙型肝炎抗病毒治療新進展,包括:抗病毒治療後清除HBsAg和降低肝內cccDNA、單藥治療、聯閤治療、NA對腎功能影響、研究和治療應答的預測等。
국제학술계주류관점화WHO추천의견:즉사재흠발체국가,잉연요창조조건우선선용고효저내약적약물치료,이피면인고내약성소도치적일계렬의학화위생경제문제。본문복습만성을형간염항병독치료신진전,포괄:항병독치료후청제HBsAg화강저간내cccDNA、단약치료、연합치료、NA대신공능영향、연구화치료응답적예측등。
The international circle of the studies on antiviral treatment of chronic hepatitis B ( CHB) and the WHO both recommend that in treating CHB the medicine with high effectiveness and low drug-resistance should be prescribed for the patients, especially for those of the developing countries.The paper presents a review of the newly developed therapies for antiviral treatment of CHB, which include methods such as ‘cleansing HBsAg and reducing cccDNA after antiviral therapy’ ,‘monomedicine therapy ’ , and ‘combined medicine therapy ’ .It as well reviews studies on kidney damage associated with NA and those on‘predictors of response’ .